King’s College London spinout Nuclide Therapeutics is pioneering a new radioactive treatment targeting cancers that resist chemo and radiotherapy.
A £5m investment will now fund its first clinical trial in lung cancer patients.
www.kcl.ac.uk/news/kings-spin-out-nuclide-...
#WorldCancerDay